ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Micafungin Impurity H
C56H70N9NaO23S
1292.3 g/mol
Pharmaceutical Intermediate

Micafungin Impurity H

CAS1392514-05-4
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Micafungin Impurity H is a sodium salt complex used as a pharmaceutical impurity reference standard. It is a highly polar, multi-ring compound with numerous alcohol and amide groups, primarily employed in quality control for micafungin-related products.

Pharmaceutical impurity reference standardQuality control in micafungin manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Micafungin Impurity H?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Nalpha-Fmoc-L-lysine hydrochloride

CAS139262-23-0

pharmaceutical intermediate

ReferenceSame Category

2-Methoxy-2-oxoethyl [2-(2,6-dichloroanilino)phenyl]acetate

CAS139272-66-5

pharmaceutical intermediate

ReferenceSame Category

2-Ethoxy-2-oxoethyl [2-(2,6-dichloroanilino)phenyl]acetate

CAS139272-67-6

pharmaceutical intermediate

ReferenceSame Category

Aceclofenac Tert-Butyl Ester

CAS139272-68-7

pharmaceutical intermediate

Referencestereoisomer of

Micafungin sodium

CAS208538-73-2

pharmaceutical raw material

Referencestereoisomer of

Micafungin

CAS235114-32-6

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

sodium [5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] sulfate

InChIKey

KOOAFHGJVIVFMZ-DWJWBOJASA-M

SMILES

CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)[C@@H](CC(=O)N)O)C)O)O)O.[Na+]

Synonyms (3)
  • Micafungin Epimer Impurity
  • Micafungin Impurity H

Sourcing Micafungin Impurity H?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→